In addition, the immunofluorescence outcomes similarly showed a decrease in GLT‐1+GFAP+/GFAP+ in the hippocampus of T2DM group and T2DM + A/S group (Figure 2C,D). This evidence concerns the gene SLC1A2 and type 2 diabetes mellitus.